Interferon beta-1b increases interleukin-10 in a model of T cell-microglia interaction: Relevance to MS

Neurology

Volumn 55, Issue 10, 2000, Pages 1497-1505

  Chabot, S ^a   Yong, V Wee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; INTERFERON BETA SERINE; INTERLEUKIN 10;

ARTICLE; CELL CULTURE; CELL INTERACTION; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; MICROGLIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0034727624     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.10.1497     Document Type: Article

References (52)

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
2. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
3. Interferon-beta-1b is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial
4. Impact of interferon beta-1a on neurological disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
5. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group
6. Interferon beta in the treatment of multiple sclerosis: Mechanisms of action
7. Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human-T cells
8. VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta
9. Interferon-beta inhibits activated leukocyte migration through brain microvascular endothelial cell monolayer
10. Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9
11. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis
12. Interferon (IFN)-beta treatment enhances CD95 and interleukin-10 expression but reduces interferon-gamma producing T cells in MS patients
13. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis
14. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
15. Cytokine analysis in multiple sclerosis by competitive RT-PCR: A decreased expression of IL-10 and an increased expression of TNF-α in chronic progression
16. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis
17. Impaired interleukin-12 production in multiple sclerosis patients
18. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: Correlation with disease phase and interferon-beta therapy
19. Interferon beta-1b treatment modulates TNF-α and IFNγ spontaneous gene expression in MS
20. Interferon-beta-1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis
21. Multiple sclerosis: Levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment
22. In vivo effects of interferonβ-1a on immunosuppressive cytokines in multiple sclerosis
23. Expression of costimulatory molecules and cytokines in CSF and peripheral blood mononuclear cells from multiple sclerosis patients
24. Experimental allergic encephalomyelitis in the absence of a classical delayed type hypersensitivity reaction: Severe paralytic disease correlates with the presence of interleukin-2 receptor-positive cells infiltrating the central nervous system
25. Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE
26. Microglia production of TNF-α is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonβ-1b
27. Biology of adult human microglia in culture: Comparisons with peripheral blood monocytes and astrocytes
28. Culture of glial cells from human brain biopsies
29. Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia
30. Mechanisms of IL-10 production in human microglia-T cell interaction
31. Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro
32. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells
33. Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis
34. Interleukin-10
35. Interleukin-10 inhibits both the production of cytokines and expression of cytokine receptors in microglia
36. Interleukin-10 down-regulates MHC class II peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling
37. Class II transactivator and class II MHC gene expression in microglia: Modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10
38. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression
39. Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: Differential regulation by T helper type 1 and T helper type 2 cytokines
40. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: Upregulation by interferon-gamma and lipolysaccahride and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents
41. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps ion specific immunotherapy
42. Maintenance of clonal anergy by endogeneously produced IL-10
43. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: Roles of interleukin-10 in disease progression and recovery
44. Interleukin-10-deficient mice develop chronic enterocolitis
45. Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts
46. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregates around sites of neuronal degeneration
47. Multiple sclerosis: Distribution of T cell subsets within active chronic lesions
48. Interferon beta induces T-helper 2 immune deviation in MS
49. Activation of the Jak-Stat pathway in cells that exhibit selective sensitivity to the antiviral effects of IFN-β compared with IFN-γ
50. Gangliosides GD1a and GM3 induce interleukin-10 production by human T cells
51. Anti-inflammatory activities of cAMP-elevating agents: Enhancement of IL-10 synthesis and concurrent suppression of TNF production
52. Effects of phosphodiesterase inhibitors on cytokine production by microglia